AI Maverick Intel Inc. (OTC: AIMV) has taken a significant step forward in its proposed acquisition of HEAL Access Canada Inc., issuing 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration. This move, announced today, follows the Right of First Refusal Agreement dated Feb. 11, 2026, and signals continued progress toward a definitive agreement between the parties.
The company also disclosed that the total consideration for the transaction has been adjusted downward from 120 million to 100 million AIMV common shares. This adjustment reflects ongoing negotiations and strategic alignment between AI Maverick Intel and HEAL Group Holdings as they work to finalize the acquisition. The transaction is part of AI Maverick Intel's broader strategy to expand its footprint in the healthcare technology sector through HEAL Access Canada, a company focused on healthcare access solutions.
In addition to the acquisition progress, AI Maverick Intel announced plans to pursue an uplisting to the OTCQB Venture Market. This capital markets strategy is intended to enhance the company's visibility and liquidity, potentially attracting a broader base of investors. The OTCQB is a premier marketplace for entrepreneurial and development-stage U.S. and international companies, and an uplisting would mark a milestone for the company as it seeks to scale its operations.
AI Maverick Intel is focused on identifying and developing opportunities at the intersection of artificial intelligence, data platforms, and emerging technology-enabled industries. The company evaluates strategic acquisitions, partnerships, and scalable platforms designed to drive long-term shareholder value. The acquisition of HEAL Access Canada aligns with this mission, leveraging AI and data analytics to improve healthcare access.
For investors, the issuance of initial consideration shares and the adjusted consideration provide clarity on the transaction's structure. The planned OTCQB uplisting could increase trading transparency and access for institutional investors. The latest news and updates relating to AIMV are available in the company’s newsroom at http://ibn.fm/AIMV.
This development is important as it demonstrates AI Maverick Intel's commitment to executing its growth strategy through acquisitions and capital markets advancements. The healthcare technology sector continues to attract investment, and AI Maverick Intel's focus on AI-driven solutions positions it to capitalize on trends in digital health. The successful completion of the HEAL Access Canada acquisition and subsequent uplisting could provide a platform for further expansion and value creation for shareholders.
